Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADTX NASDAQ:CMRA NASDAQ:EFTR NASDAQ:SMFL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADTXAditxt$0.00-6.8%$0.88$0.00▼$31,974.48$3K0.93124.91 million shs67.74 million shsCMRAComera Life Sciences$0.00$0.00▼$0.00$3K1.079,223 shsN/AEFTReFFECTOR Therapeutics$0.00$0.00$0.00▼$0.02$3K2.385,526 shsN/ASMFLSmart for Life$0.00$0.00$0.00▼$0.04$1K15.054,454 shs2,839 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADTXAditxt+41.94%-13.73%-84.78%-99.97%-100.00%CMRAComera Life Sciences0.00%0.00%0.00%0.00%-50.00%EFTReFFECTOR Therapeutics0.00%0.00%+200.00%+200.00%+200.00%SMFLSmart for Life0.00%0.00%-90.00%-66.67%-99.15%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADTXAditxt$0.00-6.8%$0.88$0.00▼$31,974.48$3K0.93124.91 million shs67.74 million shsCMRAComera Life Sciences$0.00$0.00▼$0.00$3K1.079,223 shsN/AEFTReFFECTOR Therapeutics$0.00$0.00$0.00▼$0.02$3K2.385,526 shsN/ASMFLSmart for Life$0.00$0.00$0.00▼$0.04$1K15.054,454 shs2,839 shs7 Stocks to Buy Before the Robotics RevolutionRobotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADTXAditxt+41.94%-13.73%-84.78%-99.97%-100.00%CMRAComera Life Sciences0.00%0.00%0.00%0.00%-50.00%EFTReFFECTOR Therapeutics0.00%0.00%+200.00%+200.00%+200.00%SMFLSmart for Life0.00%0.00%-90.00%-66.67%-99.15%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADTXAditxt 1.00SellN/AN/ACMRAComera Life Sciences 0.00N/AN/AN/AEFTReFFECTOR Therapeutics 0.00N/AN/AN/ASMFLSmart for Life 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest SMFL, ADTX, CMRA, and EFTR Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/24/2026ADTXAditxt Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeSell (E+) ➝ Sell (E)4/20/2026ADTXAditxt Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 7/10/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADTXAditxt$14.34K0.23N/AN/A$259.70 per share0.00CMRAComera Life Sciences$1.00M0.00N/AN/AN/ANaNEFTReFFECTOR TherapeuticsN/AN/AN/AN/A($1.94) per shareN/ASMFLSmart for Life$11.11M0.00N/AN/A($17.10) per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADTXAditxt-$41.71M-$100,788.35N/AN/AN/A-360,152.50%-374.60%-105.93%9/2/2026 (Estimated)CMRAComera Life Sciences-$18M-$0.31N/AN/AN/AN/AN/AN/AN/AEFTReFFECTOR Therapeutics-$35.81M-$13.08N/AN/AN/AN/AN/AN/A8/12/2026 (Estimated)SMFLSmart for Life-$22.68M-$14.48N/AN/AN/AN/AN/AN/A8/26/2026 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthADTXAditxtN/AN/AN/AN/AN/ACMRAComera Life SciencesN/AN/AN/AN/AN/AEFTReFFECTOR TherapeuticsN/AN/AN/AN/AN/ASMFLSmart for LifeN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADTXAditxtN/A0.060.05CMRAComera Life SciencesN/AN/AN/AEFTReFFECTOR TherapeuticsN/AN/AN/ASMFLSmart for LifeN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADTXAditxt15.54%CMRAComera Life SciencesN/AEFTReFFECTOR Therapeutics57.67%SMFLSmart for Life28.39%Insider OwnershipCompanyInsider OwnershipADTXAditxt0.01%CMRAComera Life Sciences8.90%EFTReFFECTOR Therapeutics4.70%SMFLSmart for Life31.71%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADTXAditxt60816,000816,000No DataCMRAComera Life Sciences230.74 million28.00 millionNot OptionableEFTReFFECTOR Therapeutics104.70 million4.48 millionNo DataSMFLSmart for Life1107.09 million4.84 millionNot OptionableSMFL, ADTX, CMRA, and EFTR HeadlinesRecent News About These CompaniesSmart for Life Files $30M Lawsuit Against RBSM LLPDecember 8, 2025 | tipranks.comSmart for Life Inc. (SMFL) Analyst ResearchMarch 21, 2025 | nasdaq.comHere’s How ‘Smart Cities’ Focus On Resilience And Growth No Matter Who’s PresidentNovember 14, 2024 | forbes.comSMART High School Common App WorkshopOctober 26, 2024 | volunteermatch.orgV7 Smart Tips for Living a Joyful and Purpose-Driven LifeOctober 4, 2024 | fingerlakes1.comFLucky for Life prize worth $25K a year for life won for 3rd time in a weekSeptember 30, 2024 | mlive.comMMaximize Your Products' Lifespan with These Smart TricksSeptember 29, 2024 | msn.comSmart for Life Reports Significant Balance Sheet Improvement; Achieves Over $9.4 Million in Positive Net Stockholders' Equity Following Successful Restructuring EffortsSeptember 23, 2024 | globenewswire.comSmart for Life Provides Update Following Nasdaq Delisting Due to Audit Delays; Reports Plans to Reapply to Nasdaq Upon Full ComplianceSeptember 20, 2024 | globenewswire.comEufy’s Matter-enabled smart lock is 30% off todaySeptember 19, 2024 | msn.comSmart for Life Inc (SMFL) Stock Price Reaches $0.78: What Factors Are Influencing This Level?September 19, 2024 | bovnews.comBEufy’s new smart lock may Matter to Apple Home usersSeptember 18, 2024 | msn.comSmart supramolecular assembliesSeptember 18, 2024 | sciencedaily.comSLIFX A21 SuperColor Smart Light review: Affordable Hue alternativeSeptember 16, 2024 | yahoo.comEufy’s new smart lock is the company’s first with Matter supportSeptember 16, 2024 | msn.comSmart Homes for the Elderly: Making Life Easier and SaferSeptember 16, 2024 | msn.comSmart for Life Inc (SMFL) Stock: More Resilient Than It AppearsSeptember 13, 2024 | bovnews.comBInsider Buying: Smart for Life, Inc. (NASDAQ:SMFL) Major Shareholder Buys 17,722 Shares of StockSeptember 12, 2024 | insidertrades.comHRT Financial LP Acquires New Stake in Smart for Life IncSeptember 12, 2024 | finance.yahoo.comSmart For Life Announces Participation at the H.C. Wainwright 26th Annual Global Investment ConferenceSeptember 9, 2024 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSMFL, ADTX, CMRA, and EFTR Company DescriptionsAditxt NASDAQ:ADTX$0.0041 0.00 (-6.82%) As of 03:58 PM EasternAditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.Comera Life Sciences NASDAQ:CMRAComera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company's lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.eFFECTOR Therapeutics NASDAQ:EFTR$0.0006 0.00 (0.00%) As of 07/9/2026eFFECTOR Therapeutics, Inc., a biopharmaceutical company, engages in the development of selective translation regulator inhibitors (STRIs) for the treatment of cancer. The company's lead product candidates comprise Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer; and Zotatifin, a small molecule inhibitor of eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors, as well as completed Phase 2a open-label expansion cohort in combination with fulvestrant and abemaciclib to treat patients with ER+ breast cancer. The company has a research collaboration and license agreement with Pfizer Inc. to research and develop small molecules that target eIF4E. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.Smart for Life NASDAQ:SMFL$0.0001 0.00 (0.00%) As of 07/9/2026 03:55 PM EasternSmart for Life, Inc. acquires, develops, manufactures, operates, markets, and sells nutraceutical and related products in the United States and internationally. It offers natural health and wellness meal replacement products, including nutrition bars, cookies, soups and shakes, vitamins, and supplements under the Smart for Life brand; dietary supplements; and nutritional products, including whey protein isolate powder, tablet supplements for joint health, nitric oxide, post workout blends, Omega-3 supplements, and pre-workout supplements under the Sports Illustrated Nutrition brand for athletes and active lifestyle consumers. The company also provides various nutritional products, including antioxidant rich supplements, plant-based proteins, alkalizing nutrients, and weight management products. It sells its products through online market platforms. The company was formerly known as Bonne Santé Group, Inc. and changed its name to Smart for Life, Inc. in August 2021. Smart for Life, Inc. was founded in 2002 and is based in Boca Raton, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Rocket Lab’s Stock Drop Comes With a Bullish Twist Micron's $250 Billion Bet Could Reshape the AI Memory Race AeroVironment Flies Under Wall Street’s Radar Toward a $4 Billion Target IQM's Nasdaq Debut Could Change the Quantum Race for D-Wave PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth PepsiCo’s Dividend Could Turn Patience Into Real Profit Lockheed Martin Secures the Ultimate Defense Moat Why Levi's Digital Strategy Is Paying Off in a Big Way Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
